ASSESSMENT OF MEDICATION ADHERENCE IN BIPOLAR DISORDER PATIENTS USING MEDICATION ADHERENCE TOOL
DOI:
https://doi.org/10.22159/ajpcr.2024v17i11.52521Keywords:
Bipolar disorder, Medication adherence, Morisky scale, Side effects, Cognitive impairmentAbstract
Objective: The aim of this study was to evaluate the levels of medication adherence among patients with bipolar disorder and to identify the factors associated with low adherence.
Methods: This prospective cross-sectional study was conducted over 6 months at the Psychiatry outpatient department of Silchar Medical College and Hospital, Assam, India. A total of 140 patients with bipolar disorder were recruited using consecutive sampling. Medication adherence was assessed using the Morisky 8-Item Medication Adherence Scale (MMAS-8), and demographic data were collected through structured interviews. Data were analyzed using descriptive and inferential statistics to identify factors associated with adherence.
Results: The study found that 45% of the participants had low adherence (MMAS-8 score >2), 30% had medium adherence (score 1–2), and 25% had high adherence (score 0). Factors significantly associated with low adherence included lower educational levels, unmarried status, and rural residence. Forgetfulness (58%), side effects (22%), and inconvenience (20%) were the primary reasons for non-adherence. Interventions like reminder systems were found to improve adherence rates significantly.
Conclusion: Medication adherence in patients with bipolar disorder remains suboptimal, with nearly half of the study population exhibiting low adherence. Addressing factors such as cognitive impairments, side effects, and lack of social support through tailored interventions could improve adherence and patient outcomes. Further research is needed to develop and implement strategies that address the complex barriers to adherence in this population.
Downloads
References
Selvakumar N, Menon V, Kattimani S. A cross-sectional analysis of patterns and predictors of medication adherence in bipolar disorder: Single center experience from South India. Clin Psychopharmacol Neurosci. 2018;16(2):168-75. doi: 10.9758/cpn.2018.16.2.168
Consoloni J, M’bailara K, Perchec C, Aouizerate B, Aubin V, Azorin JM, et al. Trajectories of medication adherence in patients with Bipolar Disorder along 2 years-follow-up. J Affect Disord. 2021;282:812-9. doi: 10.1016/j.jad.2020.12.192
Karaytuğ MO, Keskin N, Tamam L, Ozpoyraz N, Demirkol M. Assessment of treatment adherence in patients with bipolar disorder. J Mood Disord. 2017;1:185-90. doi: 10.5455/JMOOD.20170613090644
Babar R, Jabeen S. Predictors of medication adherence among patients with bipolar I disorder. J Prof Appl Psychol. 2023;4:213-25. doi:10.52053/jpap.v4i2.180
Uygun E, Kucukgoncu S. Treatment adherence in patients with bipolar disorder and beliefs related to non-adherence. Psychiatry Behav Sci. 2020;10:192-8. doi:10.5455/pbs.20200313091607
Ib S, Hb S, Rentala S, Nayak RB. A descriptive study to assess the drug adherence among bipolar affective disorder patients in a selected mental health care setting, Karnataka. Int J Adv Res Nurs. 2019;10:192-8. doi: 10.33545/nursing.2019.v2.i1a.26
Gutiérrez-Rojas L, Martínez-Ortega J, Pérez-Costillas L, Jiménez- Fernández S, Carretero MD, Gurpegui M, et al. Illness insight and medication adherence among patients with bipolar disorder. J Nerv Ment Dis. 2020;208:481-7. doi: 10.1097/NMD.0000000000001151
Karadağ H, Kokurcan A, Güri̇z SO, Örsel S. Assessing the treatment adherence and clinical correlates of low adherence among bipolar disorder outpatients: A cross-sectional study. Psychiatry Clin Psychopharmacol. 2018;29:558-64. doi: 10.1080/24750573.2018.1480082
Ghosal S, Mallik N, Acharya R, Dasgupta G, Mondal DK, Pal A. Medication adherence in bipolar disorder: Exploring the role of predominant polarity. Int J Psychiatry Med. 2021. doi:10.1177/00912174211030163.
Al-Taweel D, Alsuwaidan M. A medication assessment tool to evaluate prescribers’ adherence to evidence-based guidelines in bipolar disorder. Int J Clin Pharm. 2017;39(5):897-905. doi: 10.1007/s11096-017-0498-3
Bauer M, Glenn T, Alda M, Bauer R, Grof P, Marsh W, et al. Trajectories of adherence to mood stabilizers in patients with bipolar disorder. Int J Bipolar Disord. 2019;7:19. doi: 10.1186/s40345-019-0154-z
Novick D, Montgomery W, Treuer T, Aguado J, Kraemer S, Haro JM. Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: Results from a 1-year European outpatient observational study. BMC Psychiatry. 2015;15:189. doi:10.1186/s12888-015-0560-4.
Faurholt-Jepsen M, Frost M, Christensen E, Bardram JE, Vinberg M, Kessing LV. Validity and characteristics of patient-evaluated adherence to medication via smartphones in patients with bipolar disorder. Exploratory reanalyses on pooled data from the MONARCA I and II trials. Evid Based Ment Health. 2020;23(1):2-7. doi: 10.1136/ ebmental-2019-300106
Goldstein T, Krantz M, Merranko J, Garcia M, Sobel L, Rodriguez C, et al. Medication adherence among adolescents with bipolar disorder. J Child Adolesc Psychopharmacol. 2016;26(10):864-72. doi: 10.1089/ CAP.2016.0030
Etli T, Inanli I, Eren I, Caliskan AM. Several factors affecting level of treatment adherence after hospital discharge among patients with bipolar disorder. Eur Psychiatry. 2015;30:559. doi: 10.1016/S0924- 9338(15)31911-8
Corréard N, Consoloni J, Raust A, Etain B, Guillot R, Job S, et al. Neuropsychological functioning, age, and medication adherence in bipolar disorder. PLoS One. 2017;12:e0184313. doi: 10.1371/journal. pone.0184313
Stentzel U, Van den Berg N, Schulze L, Schwaneberg T, Radicke F, Langosch JM, et al. Predictors of medication adherence among patients with severe psychiatric disorders: findings from the baseline assessment of a randomized controlled trial (Tecla). BMC Psychiatry. 2018;18:155. doi: 10.1186/s12888-018-1737-4
Colom F, Vieta E, Tacchi MJ, Sánchez-Moreno J, Scott J. Identifying and improving non-adherence in bipolar disorders. Bipolar Disord. 2005;7 Suppl 5:24-31. doi: 10.1111/j.1399-5618.2005.00248.x, PMID: 16225557
Sajatovic M, Bauer MS, Kilbourne AM, Vertrees JE, Williford W. Self-reported medication treatment adherence among veterans with bipolar disorder. Psychiatr Serv. 2006 Jan;57(1):56-62. doi: 10.1176/appi. ps.57.1.56, PMID: 16399963
Kaplan G, Casoy J, Zummo J. Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophrenia. Patient Prefer Adherence. 2013 Nov 13;7:1171-80. doi: 10.2147/PPA.S53795, PMID: 24265549, PMCID: PMC3833623
Kessing LV, Hansen MG, Andersen PK, Angst J. The predictive effect of episodes on the risk of recurrence in depressive and bipolar disorders-a life-long perspective. Acta Psychiatr Scand. 2004 May;109(5):339-44. doi: 10.1046/j.1600-0447.2003.00266.x, PMID: 15049770
Gazmararian JA, Williams MV, Peel J, Baker DW. Health literacy and knowledge of chronic disease. Patient Educ Couns. 2003 Nov;51(3):267-75. doi: 10.1016/s0738-3991(02)00239-2, PMID: 14630383
Perlis RH, Ostacher MJ, Miklowitz DJ, Smoller JW, Dennehy EB, Cowperthwait C, et al. Benzodiazepine use and risk of recurrence in bipolar disorder: A STEP-BD report. J Clin Psychiatry. 2010 Feb;71(2):194-200. doi: 10.4088/JCP.09m05019yel, PMID: 20193647, PMCID: PMC9994436
Sajatovic M, Levin JB, Ramirez LF, Cassidy KA, McNamara N, Fuentes-Casiano E, et al. Long-acting injectable antipsychotic medication plus customized adherence enhancement in poor adherence patients With Bipolar Disorder. Prim Care Companion CNS Disord. 2021 Sep 16;23(5):20m02888. doi: 10.4088/PCC.20m02888, PMID: 34534421
Vervloet M, Linn AJ, Van Weert JC, De Bakker DH, Bouvy ML, Van Dijk L. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: A systematic review of the literature. J Am Med Inform Assoc. 2012 Sep-Oct;19(5):696-704. doi: 10.1136/amiajnl-2011-000748, PMID: 22534082, PMCID: PMC3422829
Published
How to Cite
Issue
Section
Copyright (c) 2024 Dr. NIVEDITA SAHA, Dr. PRANAB DAS, Dr. DOLLY ROY
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
